Filing Details

Accession Number:
0001415889-16-007518
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-02 17:16:10
Reporting Period:
2016-12-01
Filing Date:
2016-12-02
Accepted Time:
2016-12-02 17:16:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1167419 Bioptix Inc. APPY In Vitro & In Vivo Diagnostic Substances (2835) 841553387
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1373203 C Barry Honig 555 South Federal Highway #450
Boca Raton FL 33432
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-01 7,484 $4.95 477,669 No 4 P Direct
Common Stock Acquisiton 2016-12-01 1,000 $5.32 478,669 No 4 P Direct
Common Stock Acquisiton 2016-12-01 1,000 $5.30 479,669 No 4 P Direct
Common Stock Acquisiton 2016-12-01 1,600 $5.00 481,269 No 4 P Direct
Common Stock Acquisiton 2016-12-01 18,731 $5.05 500,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes (i) 439,585 shares of common stock held by GRQ Consultants, Inc. 401K ("401K") and (ii) 30,600 shares of common stock held by GRQ Consultants, Inc. Roth 401K FBO Barry Honig ("Roth 401K"). Mr. Honig is the trustee of 401K and Roth 401K in such capacity holds voting and dispositive power over the securities held by such entities.